Manager × security

STONERIDGE INVESTMENT PARTNERS LLC BIIB holdings history

Who else holds this security? →

BIOGEN INC · CUSIP 09062X103 · CIK 1108831

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, STONERIDGE INVESTMENT PARTNERS LLC reported 3.41K BIIB (shares), valued at $693.00K, or 0.45% of its reported non-derivative portfolio. Filed 2026-08-06.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.45%
Shares
3.41K
3,414
Reported value
$693.00K
USD

Shares decreased 51.43%; reported value decreased 46.24%, and weight changed -0.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.45%3,414SEC filing ↗Filed Aug 6, 2026
Q1 20260.93%7,029SEC filing ↗Filed May 6, 2026
Q4 20251.73%14,116SEC filing ↗Filed Feb 5, 2026
Q3 20251.40%14,599SEC filing ↗Filed Oct 31, 2025
Q2 20251.38%14,599SEC filing ↗Filed Aug 11, 2025
Q1 20251.69%14,599SEC filing ↗Filed May 14, 2025
Q4 20241.85%33,799SEC filing ↗Filed Jan 28, 2025
Q3 20242.44%33,799SEC filing ↗Filed Oct 30, 2024
Q2 20242.68%30,555SEC filing ↗Filed Aug 8, 2024
Q1 20242.45%29,874SEC filing ↗Filed May 6, 2024
Q4 20232.65%24,322SEC filing ↗Filed Feb 7, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20232.65%24,322$6.29MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 7, 2024
Q1 20242.45%29,874$6.44MShares increased 22.83%; reported value increased 2.35%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 6, 2024
Q2 20242.68%30,555$7.08MShares increased 2.28%; reported value increased 9.95%, and weight changed +0.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 8, 2024
Q3 20242.44%33,799$6.55MShares increased 10.62%; reported value decreased 7.50%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 30, 2024
Q4 20241.85%33,799$5.17MShares unchanged; reported value decreased 21.11%, and weight changed -0.59 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 28, 2025
Q1 20251.69%14,599$2.00MShares decreased 56.81%; reported value decreased 61.35%, and weight changed -0.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20251.38%14,599$1.83MShares unchanged; reported value decreased 8.26%, and weight changed -0.31 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20251.40%14,599$2.04MShares unchanged; reported value increased 11.57%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 31, 2025
Q4 20251.73%14,116$2.48MShares decreased 3.31%; reported value increased 21.47%, and weight changed +0.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 5, 2026
Q1 20260.93%7,029$1.29MShares decreased 50.21%; reported value decreased 48.11%, and weight changed -0.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 6, 2026
Q2 20260.45%3,414$693.00KShares decreased 51.43%; reported value decreased 46.24%, and weight changed -0.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2026
STONERIDGE INVESTMENT PARTNERS LLC · BIOGEN INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1108831","quarter":"2026Q2","cusip":"09062X103"}

get_institutional_manager_history
{"cik":"1108831","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.